European Conference on Interventional Oncology
GENERAL - ECIO 2026

April 26 - 30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

ProgrammeDisclosures

Disclosures

The table below contains declarations of potential or actual conflicts of interest by the ECIO 2026 Scientific Programme Committee members.

PresenterDisclosureCompany
Anthony Ryan//
Fernando Gómez MuñozReceipt of grants/research supports:Boston Scientific, Medtronic
Receipt of honoraria or consultation fees:Boston Scientific, iVascular, Bayer
Participation in a company sponsored speaker's bureau:Boston Scientific, iVascular
Stefan StättnerReceipt of honoraria or consultation fees:Boston Scientific, BMS, Servier
Irene BargelliniReceipt of honoraria or consultation fees:SIRTEX, Terumom, Guerbet, Boston Scientific, EISAI, Roche, Astrazeneca
Maarten SmitsReceipt of grants/research supports:Sirtex
Receipt of honoraria or consultation fees:Phillips, GD Medical
Participation in a company sponsored speaker's bureau:Phillips, Terumo, Medtronic, Varian
Georgia TsoumakidouReceipt of honoraria or consultation fees:Boston Scientific
Christoph Zech//
Philippe PereiraReceipt of grants/research supports:Medtronic, Terumo, Immunophotonics, Varian
Receipt of honoraria or consultation fees:Medtronic, Terumo, Siemens
Participation in a company sponsored speaker's bureau:Terumo, Siemens Healthineers, Immunophotonics
Roberto CazzatoReceipt of honoraria or consultation fees:Boston Scientific, Medtronic
Inger Keussen//
Gerry O'SullivanReceipt of honoraria or consultation fees:BD, Boston Scientific, Medtronic, Cook Medical, Creganna, Marvao Medical, Whiteswell
Participation in a company sponsored speaker's bureau:BD, Boston Scientific, Medtronic, Cook Medical, Creganna, Marvao Medical, Whiteswell
David PinatoReceipt of grants/research supports:MSD, BMS, GSK
Receipt of honoraria or consultation fees:Mina Therapeutics, Galapagos, Parabilis, Boeringer Ingelheim, Ewopharma, EISAI, Ipsen, Roche, H3B, Astra Zeneca, DaVolterra, Mursla, Terumo, Avammune Therapeutics, Starpharma, LiFT Biosciences, Exact Sciences
Dirk ArnoldHonoria or consultation fees:AstraZeneca, Arcus Biosciences, Boston Scientific, Bristol Myers Squibb, CRA International, Clarivate Consulting, Daiichi Sankyo, Merck Sharp & Dohme, onkowissen, Pierre Fabre Pharma, Pfizer
Participation in a company sponsored speaker's bureau:Amgen, Aptitude Health, AstraZeneca, Art Tempi Media, Astellas, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, From Research to Practice, FOMF, GSK, lmedex, lpsen, IOMEDICO, Merck (Serono), Merck Sharp & Dohme, Medscape, KUKM, Consulting, Sanofi (Genzyme), Sirtex, Servier, Streamitup, Taiho, Takeda
Other (roles as Assoc. Editor):Elsevier (ESMO Open and Ann Oncol, Clin Colorect Cancer)
Jean PalussiereReceipt of honoraria or consultation feeds:Boston Scientific
Martijn R. MeijerinkReceipt of grants/research supports:Medtronic, Johnson & Johnson, Angiodynamics, Immunophotonics, Oncosil
Receipt of honoraria or consultation fees:Medtronic, Angiodynamics
Stock shareholder:MedPeers B.V., IO Solutions
Roberto IezziReceipt of honoraria or consultation fees:Boston Scientific, Terumo, Philips, Igea, ESAOTE, HS, ECO Medical, Sirtex Medical, Betaglue, Pharmacept